Travelcenters of America Inc
Change company Symbol lookup
Select an option...
TANNI Travelcenters of America Inc
CONN Conn's Inc
F Ford Motor Co
SYF Synchrony Financial
ES Eversource Energy
LVGO Livongo Health Inc
SJMiv.P Invesco BulletShares 2022 Hi Yld Corp Bd ETF
INTC Intel Corp
AAPL Apple Inc
VAL Valaris PLC
Go

Company profile

TravelCenters of America Inc. (TravelCenters) operates or franchises travel centers, standalone truck service facilities and standalone restaurants. The Company also collects rents, royalties and other fees from its tenants and franchisees. The Company offers a range of products and services, including diesel fuel and gasoline, as well as nonfuel products and services, such as truck repair and maintenance services, full service restaurants, quick service restaurants (QSRs), and various customer amenities. The Company’s customers include trucking fleets and their drivers, independent truck drivers, highway and local motorists and casual diners. The Company's business includes approximately 258 travel centers in 43 states in the United States primarily along the United States interstate highway system, and the province of Ontario, Canada. Its travel centers are operated under the TravelCenters of America, TA brand names, TA Express, Petro Stopping Centers and Petro brand names.

Closing Price
$25.40
Day's Change
-0.08 (-0.31%)
Bid
--
Ask
--
B/A Size
--
Day's High
25.49
Day's Low
25.40
Volume
(Average)
Volume:
3,518

10-day average volume:
4,482
3,518

Clovis Oncology to Announce Third Quarter 2019 Financial Results and Host Webcast Conference Call on November 7

8:30 am ET October 22, 2019 (BusinessWire) Print

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its third quarter 2019 financial results on Thursday, November 7, 2019, before the open of the U.S. financial markets. Clovis' senior management will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the company's results in greater detail.

The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.

Conference Call Details

Clovis will hold a conference call to discuss third quarter 2019 results on Thursday, November 7 at 8:30 a.m. ET. The conference call will be simultaneously webcast on the Company's web site at www.clovisoncology.com, and archived for future review. Dial-in numbers for the conference call are as follows: US participants (866) 393-4306, International participants (734) 385-2616, conference ID: 5045559.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191022005145/en/

SOURCE: Clovis Oncology, Inc.

Clovis Investor Contacts: 
Anna Sussman
303.625.5022
asussman@clovisoncology.com 

Breanna Burkart
303.625.5023
bburkart@clovisoncology.com

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.